Device Trial Radar · NCT06043544
Hymovis® Intra-articular Injections vs Corticosteroids Intra-articular Injections in Patients Affected by Glenohumeral Osteoarthritis:
Last checked: Nov 19, 2026Latest source record: Sep 21, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
80
Actual
Start
May 2, 2021
Primary completion
Nov 10, 2021
Study completion Mar 31, 2022
Sponsor
- Lead sponsor
- Concordia Hospital RomeAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Sep 21, 2023
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 40 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This monocentric randomized open-label study aims to assess the efficacy and safety of a treatment with medium molecular weight hyaluronic acid (HA) compared to a treatment with corticosteroids on patients affected by glenohumeral osteoarthritis.
Conditions
- Glenohumeral Osteoarthritis
Interventions
Hyaluronic Acid 24 MG in 3 mL Prefilled SyringeDevice
Patients in the treatment group received two intra-articular injections with Hymovis® (24mg/3ml) a week apart from each other
Corticosteroid injectionDrug
Patients in control group received two intra-articular injections with corticosteroids a week apart from each other.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Evaluate the pain reduction in the target shoulder compared to control groupTime frame: At 6 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Concordia Hospital
Rome, Italy
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.